Yusimry® (adalimumab-aqvh)
for Ankylosing Spondylitis

Yusimry (adalimumab-avqh) is a biosimilar to Humira, a TNF alpha blocker that helps reduce pain, inflammation, and skin symptoms in autoimmune conditions. It is used to treat rheumatoid arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, hidradenitis suppurativa, and uveitis.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Ankylosing Spondylitis - AS